Kimia Biosciences Limited

BSE:530313 Stock Report

Market Cap: ₹2.2b

Kimia Biosciences Management

Management criteria checks 3/4

Kimia Biosciences' CEO is Sameer Goel, appointed in May 2022, has a tenure of 2.75 years. directly owns 74.94% of the company’s shares, worth ₹1.64B. The average tenure of the management team and the board of directors is 2.8 years and 8.9 years respectively.

Key information

Sameer Goel

Chief executive officer

₹6.0m

Total compensation

CEO salary percentagen/a
CEO tenure2.8yrs
CEO ownership74.9%
Management average tenure2.8yrs
Board average tenure8.9yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Sameer Goel's remuneration changed compared to Kimia Biosciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2024n/an/a

₹94m

Sep 30 2024n/an/a

₹29m

Jun 30 2024n/an/a

-₹12m

Mar 31 2024₹6mn/a

-₹53m

Dec 31 2023n/an/a

-₹133m

Sep 30 2023n/an/a

-₹148m

Jun 30 2023n/an/a

-₹132m

Mar 31 2023₹6mn/a

-₹94m

Dec 31 2022n/an/a

-₹46m

Sep 30 2022n/an/a

-₹25m

Jun 30 2022n/an/a

-₹29m

Mar 31 2022₹6mn/a

-₹37m

Dec 31 2021n/an/a

-₹32m

Sep 30 2021n/an/a

-₹14m

Jun 30 2021n/an/a

₹34m

Mar 31 2021n/an/a

₹51m

Dec 31 2020n/an/a

₹52m

Sep 30 2020n/an/a

₹49m

Jun 30 2020n/an/a

₹30m

Mar 31 2020₹444k₹444k

₹14m

Dec 31 2019n/an/a

₹21m

Sep 30 2019n/an/a

₹40m

Jun 30 2019n/an/a

₹38m

Mar 31 2019₹5m₹5m

₹39m

Compensation vs Market: Sameer's total compensation ($USD69.19K) is above average for companies of similar size in the Indian market ($USD41.81K).

Compensation vs Earnings: Sameer's compensation has been consistent with company performance over the past year.

CEO

Sameer Goel (49 yo)

2.8yrs

Tenure

₹6,000,000

Compensation

Mr. Sameer Goel has been Chief Executive Officer of Kimia Biosciences Limited since May 30, 2022. He serves as Managing Director of KIMIA Biosciences Pvt. Ltd.Mr. Goel has been the Chairman, Managing Dire...

Leadership Team

NamePositionTenureCompensationOwnership
Sameer Goel
CEO, Chairman of the Board & MD2.8yrs₹6.00m74.94%
₹ 1.6b
Rakesh Chetani
Chief Financial Officer1.4yrs₹1.81mno data
Subrat Satpathy
Chief Operating Officer3.4yrs₹6.55mno data
Mathura Joshi
Assistant General Manager of Finance & Accountsno datano datano data
Pallavi Garg
Company Secretary & Compliance Officerless than a yearno datano data
Ruchita Mishra
Manager of Marketingno datano datano data
Asit Bhalerao
Chief Human Resources Officer3.3yrs₹7.00mno data
Mukesh Sharma
Head of Research & Developmentno data₹3.59mno data
Rita Sarin
Advisor of Strategy & IPR Head of Intellectual Property Rightsno datano datano data

2.8yrs

Average Tenure

49yo

Average Age

Experienced Management: 530313's management team is considered experienced (2.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Sameer Goel
CEO, Chairman of the Board & MD8.9yrs₹6.00m74.94%
₹ 1.6b
Jagdeep Dhawan
Independent Non-Executive Director8.9yrsno datano data
Richa Gupta
Independent Non-Executive Woman Director8.8yrsno datano data
Vipul Goel
Non-Executive Non Independent Director6.2yrsno data0.000030%
₹ 655.3

8.9yrs

Average Tenure

47.5yo

Average Age

Experienced Board: 530313's board of directors are considered experienced (8.9 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/16 02:26
End of Day Share Price 2025/02/14 00:00
Earnings2024/12/31
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Kimia Biosciences Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.